TNF Ligands Enhancer Protein
Spezies: Human
Wirt: Human
Recombinant
>95 % (SDS-PAGE)
-
- Target
- TNF Ligands Enhancer
- Protein-Typ
- Recombinant
- Spezies
- Human
- Quelle
- Human
- Verwendungszweck
- TNF Ligands Enhancer
- Kreuzreaktivität
- Diverse Spezies
- Reinheit
- >95 % (SDS-PAGE)
- Endotoxin-Niveau
- <0.01EU/μg purified protein (LAL test, Lonza).
- Biological Activity Comment
- Enhances biological activity of TRAIL, Soluble (human) (rec.) (AG-40B-0003) and FasL, Soluble (human) (rec.) (AG-40B-0001).
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- 1 mg/mL after reconstitution
- Konzentration
- 1 mg/mL
- Buffer
- Contains PBS.
- Handhabung
- After reconstitution, prepare aliquots and store at -20 °C.Avoid freeze/thaw cycles.Centrifuge lyophilized vial before opening and reconstitution.PBS containing at least 0.1 % BSA should be used for further dilutions.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
-
Short Term Storage: +4°C
Long Term Storage: -20°C
Use & Stability: Stable for at least 6 months after receipt when stored at -20°C.
- Haltbarkeit
- 6 months
-
- Target
- TNF Ligands Enhancer
- Hintergrund
- Enhances the biological activity of TRAIL, Soluble (human) (rec.) (AG-40B-0003) and FasL, Soluble (human) (rec.) (AG-40B-0001).
-
Sie sind hier:
